Hoya Vision Care—a front runner in optical technology innovation—has recently reported the results of the six-year follow-up clinical study done on MiYOSMART Spectacle lens.
The results presented compelling evidence that with long-term continued use, the award-winning MiYOSMART spectacle lens with D.I.M.S. Technology is effective in slowing down the progress of myopia (near-sightedness) in children.
Natalia Vlasak, the Global Head of Medical and Scientific Affairs at HOYA Vision Care said, “This six-year follow-up clinical study on the MiYOSMART spectacle lens—the longest study conducted on a myopia management spectacle lens ever—shows that the myopia control effects are sustainable over time which is very exciting news.”
“This study also answered another key question from eye care professionals, which was about the rebound effect of the lens. We are very pleased that this clinical study proves that there is no rebound effect if lens use is stopped,” Natalia added.
The advantages of the six-year mark findings extend a previous three-year follow-up study1. Moreover, they are part of a continuation of a two-year randomised control trial (R.C.T.)2, as published in the British Journal of Ophthalmology.
Here at Island Optical, we get super excited about the latest news and discoveries on optical technology, as well as the future of optics. We’re always happy to tell you about major developments and promising ventures—and the revolutionary MiYOSMART spectacle lens technology only signifies that there are more good things to come!
Please reach out to our well-qualified staff and professionals at any of our 60+ locations Australia-wide for any enquiries you may have. Online appointment booking is now available!
1 Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Published Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664
2 Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739